Accumulation of amyloid ␤-peptide (A␤) and tau aggregates, possibly linked to age-associated deficiencies in protein homeostasis, appear to cause Alzheimer's disease. Schiff-base formation between A␤ and the aldehyde-bearing cholesterol oxidation product 3-␤-hydroxy-5-oxo-5,6-secocholestan-6-al is known to increase A␤ amyloidogenicity. Here, we synthesized A␤ variants site-specifically modified with the cholesterol aldehyde at Asp-1, Lys-16, or Lys-28, rather than studying mixtures. These distinct modifications have a similar effect on the thermodynamic propensity for aggregation, enabling aggregation at low concentrations. In contrast, the modification site differentially influences the aggregation kinetics; Lys-16-modified A␤ formed amorphous aggregates fastest and at the lowest concentration (within 2 h at a concentration of 20 nM), followed by the Lys-28 and Asp-1 conjugates. Also, the aggregates resulting from A␤ Lys-16 cholesterol aldehyde conjugation were more toxic to primary rat cortical neurons than treatment with unmodified A␤ under identical conditions and at the same concentration. Our results show that A␤ modification by cholesterol derivatives, especially at Lys-16, renders it kinetically and thermodynamically competent to form neurotoxic aggregates at concentrations approaching the physiologic concentration of A␤.
ging, associated with decreasing protein homeostasis (proteostasis) capacity and increasing oxidative stress, is a prominent amyloid disease risk factor (1, 2) . The hallmark of these maladies is tissue-selective deposition of amorphous and/or fibrillar cross-␤-sheet-rich protein assemblies called amyloid (3). Alzheimer's disease (AD) (4) is the most common amyloid disease, afflicting Ͼ5 million people over age 65 in the United States (5) . AD appears to be exacerbated by, if not caused by, defects in proteostasis that lead to intra (6) and extracellular amyloid ␤-peptide amyloidogenesis (A␤; 39-43-residue peptides produced by endoproteolytic processing of the amyloid precursor protein) (4) , and to intracellular aggregation of tau (7) . The 40-residue form of A␤ (A␤ 40 ) is most prevalent (8) , whereas longer variants, especially the 42-residue form (A␤ 42 ), are the most amyloidogenic (9) . The longer variants dominate A␤ deposits in the brains of patients with AD (10) and their levels are elevated in some familial forms of AD (11) .
An important concept in the thermodynamics of amyloidogenesis is the critical concentration, the concentration below which amyloid cannot form (12) . The A␤ 40 critical concentration has been reported to be in the range of 1-30 M (9, 13, 14) . However, the physiologic concentration of A␤ 40 in CSF is in the low nanomolar range (8) . As mentioned above, A␤ 42 is more amyloidogenic than A␤ 40 , but its concentration is Ϸ10-fold lower than that of A␤ 40 (8) , so its critical concentration is still Ͼ100-fold higher than its physiologic concentration. How A␤ 40 and A␤ 42 aggregate in vivo when their physiologic concentrations are lower than their critical concentrations is one of the many mysteries of AD.
A related issue involves the kinetics of amyloid formation. A␤ is thought to undergo amyloidogenesis by a nucleated polymerization mechanism, which has two phases: a lag phase involving nucleation, followed by a fibril growth phase (12) . The duration of the lag phase increases exponentially as concentration decreases, becoming very long when the concentration is close to the critical concentration (12) . Thus, A␤ amyloidogenesis has both thermodynamic and kinetic barriers in vivo.
We have proposed that reversible covalent modification of A␤ by small molecule oxidation products, in combination with factors like adsorption to the extracellular matrix or membranes (15) , can explain the ability of A␤ to form amyloid at physiologic concentrations (16) (17) (18) . Small molecule oxidation products are generated when reactive oxygen species react with double bonds, including those of hydrophobic membrane components (19) . The concentrations of the resulting hydrophobic aldehydes that can modify proteins through reversible Schiff base formation increase during aging and peak during oxidative stress (20) . Both aging and oxidative stress are risk factors for AD (4, 19) ; in fact, small molecule oxidation products are found at elevated levels in the brains of individuals with AD (16, 19, 21, 22) .
We and others have found that the naturally occurring small molecule oxidation products 4-hydroxynonenal (23) and 3␤-hydroxy-5-oxo-5,6 secocholestan-6-al (see 1 in Fig. 1A) , derived from cholesterol, and the aldol product of the latter (see 2 in Fig.  1 A) (24) , covalently modify A␤ and increase its amyloidogenicity (16) (17) (18) (25) (26) (27) . Prior data indicated that cholesterol oxidation products 1 and 2, denoted 1(2) hereafter because they interconvert via an aldol/retro-aldol reaction (16, 18, 24) , react with A␤ via Schiff base formation at the N-terminal ␣-amine of Asp-1 (D1) and the side-chain -amines of Lys-16 (K16) and Lys-28 (K28) (18) . Compounds 1 and 2 have been detected by us (18, 28) and others (29) in ex vivo human and rat brain samples at combined concentrations of up to 400 pg/mg of wet brain (Ϸ1 M concentration). Scheinost et al. (27) recently suggested that K16 is the ''hot spot'' for A␤ aggregation induced by 1(2) modification. We previously reported that adduct formation between A␤ 40 and 1(2) decreased the aggregation critical concentration to Ͻ100 nM (the limit of detection of the method used) (18) , changed the aggregation mechanism from a nucleated to a downhill polymerization (17) , and resulted in the formation of spherical aggregates when incubated quiescently (17, 18) , which are reported to be neurotoxic (30) . Thus, a spike in the concentration of these hydrophobic aldehydes (e.g., caused by trauma or inflammation) could trigger A␤ aggregation and then become traceless if the aldehyde concentrations later decrease because of the reversibility of Schiff base formation. However, significant questions about the modification of A␤ by 1(2) persist, including: Why is K16 a hot spot for covalentmodification-induced A␤ aggregation? Does modification by 1(2) lower the critical concentration of A␤ aggregation into the physiologic concentration range? Can A␤ modified by 1(2) aggregate at low concentrations on a biologically relevant time scale? And, are the aggregates formed by A␤-1(2) conjugates toxic to primary neurons and what is their toxicity relative to unmodified A␤? We address these questions here. Methods) . Note that the hydrolytically unstable Schiff-base linkage between 1(2) and A␤ was reduced to a secondary amine in each peptide-1(2) conjugate (Fig. 1C) . Although this permanent covalent linkage through a secondary amine is less conformationally constrained than a Schiff base, it retains the positive charge at neutral pH and the ability to adopt a Schiff baseequivalent conformation of the hydrophobic appendage enabling aggregation at low concentrations.
Results

Synthesis of A␤
Monomerization of A␤40, A␤42, and the A␤40-1(2) Conjugates. Before studying the amyloidogenesis of A␤ 40 -1(2) conjugates, they must be monomerized. Because the A␤ 40 -1(2) conjugates are extremely aggregation prone, the high-pH pretreatment method of Fezoui et al. (31) that we used previously to monomerize A␤ 40 (17, 18, 23) was not effective (Fig. S1 ). Instead, we monomerized the A␤ 40 -1(2) conjugates by dissolving them in 8 M guanidine hydrochloride (GuHCl) in phosphate buffer [50 mM sodium phosphate (NaPi), pH 7.5]. Solutions of monomeric A␤ variants in 8 M GuHCl were prepared for use by one of three methods.
(i) Solutions of A␤ variants for equilibrium aggregation experiments were simply filtered through a 0.2-m filter and diluted to the desired peptide and GuHCl concentrations. (ii) Solutions of A␤ variants for kinetic experiments, requiring rigorously monomeric A␤, were obtained by preparative size exclusion chromatography (SEC) using 8 M GuHCl as the mobile phase. (iii) GuHCl-free solutions of A␤ variants were prepared by passing the GuHCl solution through a short SEC column eluted with phosphate buffer (for further details, see SI Materials and Methods).
Critical Concentrations of the A␤40-1(2) Conjugates. The critical concentration for aggregation, c agg , is equivalent to the concentration of the monomeric protein left in solution when aggregation reaches equilibrium (12, 32) . In principle, c agg can be determined by allowing aggregation to reach equilibrium and measuring the concentration of A␤ 40 monomer remaining in solution (32) . However, the c agg values of A␤ 40 -1(2) conjugates are well below the detection thresholds of most protein concentration determinations (18) , so direct measurements are challenging, if not impossible.
Instead, we used a chaotrope denaturation strategy to estimate the c agg values of A␤ 40 -1(2) conjugates. As suggested by Narimoto et al. (33) , the free energy of aggregation, ⌬G agg , like the free energy of protein folding, should depend linearly on GuHCl concentration, as should the natural logarithm of c agg , because ⌬G agg ϭ ϪRT ln c agg (R is the gas constant and T is the temperature). Thus, c agg should depend on GuHCl concentration as follows:
where [GuHCl] is the concentration of GuHCl, c agg,0 is the critical concentration at 0 M GuHCl, and m agg /RT is the slope of a plot of ln c agg vs. [GuHCl] . According to Eq. 1, c agg,0 can be determined by measuring c agg at a series of GuHCl concentrations, plotting ln c agg vs.
[GuHCl], and extrapolating to 0 M GuHCl. The aggregate denaturation method described above was implemented as follows. A␤ 40 , A␤ 42 , and the A␤ 40 -1(2) conjugates were monomerized by method i. Solutions of each variant were diluted to make a set of solutions with increasing GuHCl concentrations but constant A␤ concentration. These sets of solutions were incubated at 37°C under constant agitation for at least 5 days, after which they were filtered through a 0.2-m filter, and the value of c agg was determined by measuring the monomer concentration using the integrated peak intensities in a size exclusion chromatogram. To ensure that denaturation was reversible, preformed aggregates were also placed in increasing concentrations of GuHCl and c agg was determined. The aggregates in question were fibrillar for A␤ 40 and A␤ 42 and amorphous for the A␤ 40 -1(2) conjugates. The c agg values determined by approaching the aggregate-monomer equilibrium from the monomer or aggregate direction are plotted together vs.
[GuHCl] for the A␤ variants in Fig. 2A . As expected for a true equilibrium, the c agg values from the two methods are consistent and are fit to a single line. Fig. 2B (left axis, solid blue circles) shows the c agg,0 values extrapolated from Fig. 2 A. The critical concentration of A␤ 40 determined by this method (850 nM) is similar to that determined previously by O'Nuallain et al. (14) . The critical concentration of A␤ 42 determined by this method is 160 nM, substantially lower than that of A␤ 40 , as expected (9) .
The critical concentrations of A␤ 40 -1(2) D1 , A␤ 40 -1(2) K16 , and A␤ 40 -1 (2) K28 determined by the denaturation method (Fig. 2B ) are the same within experimental error, averaging Ϸ4 nM. This value of c agg is Ͼ200-fold lower than that of A␤ 40 and 40-fold lower than that of A␤ 42 . The effect of the modification of A␤ 40 by 1(2) on A␤ 40 aggregation thermodynamics is apparently strong enough to drive c agg,0 of the A␤ 40 -1(2) conjugates into the physiologic concentration range of A␤, and is independent of the site of modification.
The slopes of the plots of ln c agg vs.
[GuHCl] in Fig. 2 A for the A␤ variants are also plotted in Fig. 2B (right axis, solid gray circles). The A␤ 40 40 and A␤ 42 , respectively. The value of m agg should be proportional to the accessible surface area buried during aggregation (34) . Assuming that m agg increases by 2.2 ϫ 10 Ϫ4 kcal mol Ϫ1 M Ϫ1 GuHCl per Å 2 of buried surface area (34) , the difference in m agg values suggests that the A␤ 40 -1(2) conjugates bury Ϸ900 Å 2 more surface area on aggregation than unmodified A␤ 40 , comparable with the accessible surface area of cholesterol (Ϸ670 Å 2 ).
Aggregation Kinetics of A␤40-1(2) Conjugates Monitored by Light
Scattering. Samples for studying the aggregation rates of the A␤ 40 -1(2) conjugates were monomerized by method ii, yielding rigorously monomeric A␤ 40 -1(2). The fractions corresponding to monomeric A␤ 40 -1(2) were collected, diluted so that the GuHCl concentration was 0.8 M, and the peptide concentration was as desired, and aggregation was monitored (without agitation) by the intensity of the light scattered at 90°, ⌬I s (90°). The aggregation time courses of A␤ 40 , A␤ 42 , and the A␤ 40 -1(2) conjugates at 37°C in phosphate buffer (50 mM NaPi/300 mM NaCl, pH 7.5) with 0.8 M GuHCl present are plotted in Fig. 3A (500 nM) and 3B (100 nM). Unmodified A␤ 40 and A␤ 42 did not aggregate on the time scale of these experiments (2 h) at concentrations of 500 nM. In contrast, the A␤ 40 -1(2) conjugates showed evidence of aggregation within 2 h at a concentration of 500 nM (Fig. 3A) . Unlike aggregation thermodynamics, the aggregation rates of the A␤ 40 -1(2) conjugates depended strongly on the modification site. A␤ 40 -1 (2) K16 aggregated faster than A␤ 40 -1 (2) K28 , which aggregated faster than A␤ 40 -1(2) D1 . This ordering is maintained at concentrations of 100 nM, except that A␤ 40 -1 (2) D1 no longer aggregated within 2 h (Fig. 3B) . Although the light scattering data were noisy at even lower A␤ 40 -1(2) concentrations, A␤ 40 -1 (2) K16 and A␤ 40 -1(2) K28 still aggregated at concentrations of 50 nM, the limit of detection (aggregation reactions at 20 nM were examined, but exhibited no signal above the background; see Fig. S2 ).
Immuno-Electron Microscopy of Samples from Low Concentration
Light Scattering Experiments. Samples from the low concentration light scattering time courses were examined by immuno-EM to ensure that the aggregates detected were composed of A␤ 40 -1(2), and to attempt to detect aggregates at even lower concentrations. Aliquots (50 L) were removed from the aggregation reactions after 2 h and applied to EM grids. These EM grids were incubated with a monoclonal anti-A␤ antibody (6E10) followed by protein A (which binds to 6E10) conjugated to 10-nm gold particles. The resulting EM images are shown in Fig. 4 and Fig.  S3 (for experimental details, see SI Materials and Methods). No aggregates were observed in samples of A␤ 40 after 2 h of aggregation at a concentration of 500 nM (Fig. 4A ), but gold particles were readily visible covering samples of A␤ 40 fibrils formed at 25 M (Fig. 4B) . A␤ 42 also showed no evidence of aggregation at 500 nM after 2 h (Fig. 4C) , despite this concentration being above its apparent critical concentration. The remaining panels of Fig. 4 show images from the lowest concentration samples in which aggregates could be found in the 2-h aggregation reactions of the A␤ 40 -1(2) conjugates. Amorphous aggregates were detected at 500 nM for A␤ 40 -1(2) D1 (Fig. 4D ), at 20 nM for A␤ 40 -1 (2) K16 (Fig. 4E) , and at 100 nM for A␤ 40 -1 (2) K28 (Fig. 4F) . Given that these are the minimal concentrations at which aggregates could be detected, the aggregates shown in Fig. 4 D-F were infrequently detected on the EM grids, as expected. Utilization of an A␤-specific antibody guarantees that the aggregates are composed of A␤. Also, the fact that aggregates are not observed in the unmodified A␤ samples suggests that they are not spurious. These results extend the light scattering data described above by demonstrating that A␤ 40 -1(2) K16 aggregates at concentrations below the light scattering detection limit.
Aggregation Kinetics of the A␤40-1(2) Conjugates Monitored by Thioflavin T (TfT) Fluorescence. A␤ 40 , A␤ 42 , and the A␤ 40 -1(2) conjugates were monomerized by method iii and diluted to a concentration of 10 M in phosphate buffer (50 mM NaPi/300 mM NaCl, pH 7.5). Their TfT-monitored aggregation time courses are shown in Fig. S4 . Aggregates that yield a TfT fluorescence signal do not necessarily have classic fibrillar morphologies (17, 18, 35, 36) , and therefore, will be termed ''microfibrillar.'' These experiments were performed with mild agitation (5 s of shaking every 10 min) to encourage the transition to microfibrillar aggregates (17) . Microfibrillar aggregates appeared fastest for A␤ 40 -1(2) D1 , followed by A␤ 40 -1(2) K16 and then A␤ 40 -1(2) K28 , although more slowly in every case than the aggregates detected in the light scattering experiments, despite higher concentrations being used. This result suggests that the amorphous aggregates detected by light scattering are TfT-negative (i.e., they are not microfibrillar), and the amorphous aggregates either form first and then convert to microfibrillar aggregates or the amorphous and microfibrillar aggregates form in parallel with the amorphous aggregates appearing somewhat faster. We prefer the first explanation, because the second implies that the TfT-negative amorphous aggregates are off-pathway. The TfT-monitored time courses are not consistent with amyloidogenesis with off-pathway aggregates, because the TfT fluorescence does not increase quadratically with time, as required by off-pathway aggregation (37) . Also, we have shown previously that amorphous aggregates formed by A␤ 40 -1(2) conjugates can convert directly to fibrils on seeding or agitation (17, 18) . K16 to Primary Neurons. Although modification of A␤ 40 with 1(2) dramatically lowers c agg,0 and hastens aggregate formation, whether these aggregates are toxic to primary neurons is unknown. The neurotoxicities of A␤ 40 and A␤ 40 -1 (2) K16 were compared by first monomerizing each variant by method iii, except that the peptides were eluted from the gel filtration column with HBSS. A␤ 40 and A␤ 40 -1 (2) K16 were incubated in HBSS for 8 h at 6.75 to 50 M (3ϫ the final toxicity assay concentration) at room temperature under quiescent conditions. After the incubation period, glial-cell-free primary rat cortical neurons (Fig. S5) were incubated for 48 h with varying concentrations of the A␤ peptides (0-to 16.67-M final concentration) in cell culture media. The solutions of unmodified A␤ 40 had little effect on cell viability/ metabolic activity relative to buffer control at all concentrations under these aggregation conditions (Fig. 5) , as determined by a resazurin assay (38) . This result is consistent with our previous observation that rigorously monomerized, unmodified A␤ 40 does not aggregate within 8 h when it is not agitated (17, 18) . In contrast, the solutions of A␤ 40 -1 (2) K16 were toxic to cells at concentrations Ͼ4.17 M (up to a 45 Ϯ 4% reduction in cell viability at 16.67 M relative to buffer-treated controls; Fig. 5 ). The deleterious effect of A␤ 40 -1 (2) K16 aggregates on the neurons are also apparent from the altered cell morphologies. Phase K28 at a concentration of 100 nM. Aggregates of A␤ 40-1(2) conjugates were not detected by this method in samples at concentrations lower than those noted in D-F. Additional immuno-EM images are shown in Fig. S3.   Fig. 5 . Neurotoxicity of A␤40 vs. A␤40-1(2) K16 . A␤40 (black) and A␤40-1(2) K16 (green) were subjected to aggregation conditions quiescently for 8 h (6.75 M to 50 M, 3ϫ the final concentration used in the toxicity assay) and applied to primary rat cortical neurons at final concentrations ranging from 0 to 16.67 M. After 48 h of incubation, the viability of the cells was assessed by resazurin fluorescence. Viability is shown as a percentage of the metabolic activity of cells treated with buffer alone. Data are from independent triplicates, and the error bars are for SEM. Fig. S6 , which reveals neuron atrophy and disruption of neural connections only in A␤ 40-1(2) K16 -treated neurons, further supports the toxicity of A␤ 40-1 (2) K16 , but not A␤40 under these aggregation conditions.
Toxicity of the Aggregates Formed by A␤40-1(2)
contrast microscopy images of primary rat cortical neurons incubated for 48 h with HBSS or A␤ 40 at a final concentration of 16.67 M revealed healthy neurons that formed interconnected networks (Fig. S6 A and B) . However, primary rat cortical neurons incubated for 48 h with A␤ 40 -1(2) K16 at an identical concentration exhibited atrophy, clumping, and a loss of neural connections (Fig. S6C ). These results demonstrate that the A␤ 40 -1(2) conjugate at K16 forms neurotoxic aggregates under conditions where A␤ 40 does not.
Discussion
We have shown that the A␤ 40 -1(2) conjugates are thermodynamically and kinetically competent to form amorphous aggregates in vitro at concentrations close to the physiologic concentration of A␤. However, their kinetic competence, unlike their thermodynamic competence, depends strongly on the site of modification. A␤ 40 -1(2) K16 forms aggregates most rapidly and at the lowest concentration (within 2 h at a concentration of 20 nM), followed by A␤ 40 -1 (2) K28 and A␤ 40 -1(2) D1 . This ranking matches the local hydrophobicity of the A␤ sequence at the modification site: K16 resides in the most hydrophobic context (…VHHQKLVFF…), followed by K28 (…VGSNKGAII…), and then D1 (DAEFRHDSG…). This correlation between local hydrophobicity and the kinetic effect of metabolite modification suggests that K16 and its surrounding residues were already important for aggregate nucleation and growth, consistent with previous findings (39) , and that the increase in hydrophobicity attendant to the attachment of 1(2) to K16 magnifies the influence of this region. Thus, it is a hotspot for hydrophobic metabolite modification-mediated aggregation. Fig. S4 shows that the formation of microfibrillar species is fastest for A␤ 40 -1(2) D1 , followed by A␤ 40 -1(2) K16 , and then by A␤ 40 -1(2) K28 . This ranking matches the proximity of the modification to the N terminus rather than correlating with local hydrophobicity. We posit that the microfibrillar species result from conformational rearrangements within the initially-formed amorphous aggregates, consistent with the expectation that the transition from the TfT-negative amorphous aggregates to microfibrillar aggregates requires larger conformational changes at K28 and K16 than at D1, which is known to be disordered in structural models of fibrillar A␤ (40, 41) .
Our observation that A␤ 40 -1(2) D1 and A␤ 40 -1(2) K28 are highly aggregation prone appear to contradict the results of Scheinost et al. (27) , who reported that A␤ 40 variants in which Schiff base formation was blocked at the -amine of K16 did not form TfT-positive aggregates in the presence of 1(2), even when the ␣-amine of D1 and the -amine of K28 were available. Our results can be reconciled with those of Scheinost et al. (27) by noting that Schiff base formation is reversible and Schiff bases are unstable in aqueous solution. Therefore, the concentration of A␤ 40 -1(2) conjugates should be low when A␤ 40 is mixed with exogenous 1(2). Our results show that A␤ 40 -1 (2) K16 , which aggregates most rapidly at the lowest concentration, should be best able to aggregate under such conditions.
It is likely that no single factor will fully explain the pathogenesis of AD. AD probably results from the balance between A␤ aggregation and aggregate clearance tipping toward the former on aging, leading to aggregate accumulation, neurotoxicity, and memory loss. It is probable that the sum of all of the factors that either promote aggregation or diminish aggregate clearance determine whether an individual will become afflicted with AD. We have shown that A␤ modification by the oxidized cholesterol metabolite 1(2), especially at K16, could be an especially potent promoter of A␤ aggregation. A␤ 40 -1(2) K16 is, to our knowledge, the only A␤ variant that is kinetically and thermodynamically competent to aggregate at concentrations approaching the physiologic concentration of A␤. Also, we have demonstrated that the aggregates formed by A␤ 40 -1 (2) K16 are toxic to primary neurons. These observations, especially when considered with the previous demonstration that A␤ 40 -1(2) conjugates can induce unmodified A␤ to coaggregate (18) , suggest that metabolite-initiated amyloid formation could contribute to AD pathogenesis. These data also imply that inhibiting A␤ modification by oxidized metabolites by using aldehydesequestering compounds or the equivalent could be a viable preventative strategy against AD (16, 17, 42) . However, future efforts will be required to better understand the role of membrane component-derived Schiff base modifications of A␤ in the etiology of AD.
Methods
For detailed descriptions of the synthesis of A␤ variants site-specifically modified with 1(2) and the procedures for monomerization, immuno-EM, TfT-monitored aggregation kinetics, and the primary rat cortical neuron-based toxicity assay, see SI Materials and Methods. The solvent accessible surface area of cholesterol was determined by using ChemBio3D Ultra (probe radius ϭ 1.4 Å).
Estimating Critical Concentrations Using GuHCl Denaturation and SEC. Solutions of A␤40, A␤42, A␤40-1(2) D1 , A␤40-1(2) K16 , and A␤40-1(2) K28 monomerized by method i (see SI Materials and Methods) were diluted to a peptide concentration of 100 M and GuHCl concentrations ranging from 2 to 8 M in 1 M increments. These solutions were incubated with agitation using an EchoTherm RT10 rotating mixer (Torrey Pines Scientific) at 20 rpm for Ͼ5 days at 37°C to enable aggregation. Alternately, preformed aggregates of each A␤ variant were prepared by monomerizing the peptides by method i, diluting to a peptide concentration of 100 M and a GuHCl concentration of 0.8 M, and incubating at 37°C with agitation as above for Ͼ5 days. Preformed aggregates were also prepared by directly dissolving the A␤ variants in buffer and incubating at 37°C with agitation. Solutions of preformed aggregates, prepared with or without monomerization, were diluted to final peptide concentrations of 10 or 100 M, respectively, and final GuHCl concentrations between 2 and 8 M to denature aggregates, and then incubated with agitation (20 rpm, 37°C, Ͼ5 days).
Aggregation and aggregate denaturation solutions were filtered through a 0.22-m syringe filter (Millipore). Samples (100 L) were injected onto an AKTA FPLC employing a Superdex 75 HR 10/30 SEC column (GE Healthcare) and eluted with 50 mM sodium phosphate (pH 7.5, 0.02% NaN3) containing GuHCl at the same concentration as the injected sample. A␤ variants were detected by absorbance at 280 nm. Concentrations of monomeric A␤ variants were determined from the integrated intensity of the monomer peaks.
Kinetics of Aggregation of A␤ Variants
Monitored by Light Scattering. Seed-free solutions of A␤40, A␤42, and A␤-1(2) conjugates in 8 M GuHCl prepared by method ii (see SI Materials and Methods) were diluted with 8 M GuHCl to 10ϫ the desired final peptide concentration. These solutions were then diluted 10-fold in phosphate buffer (50 mM NaPi/300 mM NaCl, pH 7.5) so that the GuHCl concentration was 0.8 M and the peptide concentration was as desired. Samples (5 mL) were transferred to 25 mL scintillation vials, which were placed in a Dawn EOS light scattering photometer (Wyatt Technology) with a Peltier temperature controller. Light scattering intensity data at 90°offset by the intensity at t ϭ 0 min, or ⌬Is (90°), were collected for 2 h at 37°C.
